Source: Global Legal Chronicle

Keensight Capital: Biovian's Partnership with 3P Biopharmaceuticals.

Paul Hastings (Europe) LLP, Strelia, Garrigues and Castrén & Snellman advised Keensight Capital on the matter. Biovian and 3P Biopharmaceuticals ("3P"), two leading biologics Contract Development [...].

Read full article »
Keensight Capital's Competitors | Keensight Capital's News | Keensight Capital's Financials
Stay up-to-date with the latest news on Keensight Capital
Est. Annual Revenue
$25-100M
Est. Employees
25-100
Ana Alvarez Grullon's photo - Managing Director of Keensight Capital

Managing Director

Ana Alvarez Grullon

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Keensight Capital